20234480 #40356434.0 IRB Approved at the Protocol Level Apr 15, 2024 Seeking Participants with Multiple Sclerosis for Clinical Trials FREXALT CLINICAL TRIAL The FREXALT Trial The Frexalt trial designed for men and women between the ages of 18 and 55, diagnosed with Relapsing Multiple Sclerosis (RMS). The investigational medication will be given every four weeks intravenously (IV). This trial is seeking 1400 participants. FREVIVA CLINICAL TRIAL The FREVIVA Trial The Freviva trial designed for men and women between the ages of 18 and 60, diagnosed with Secondary Progressive Multiple Sclerosis (SPMS). The investigational medication will be given every four weeks intravenously (IV). This trial is seeking 865 participants. Consultants in Neurology CLINICAL RESEARCH 1535 Lake Cook Road, Suite 601 Northbrook, IL 60062 TEL: 847-509-0270 FAX: 847-770-6227 EFC17919 (FREXALT) EFC17504 (FREVIVA) Poster V1.0 22 March 2024 20234480 # 40356434.0 IRB Approved at the Protocol Level Apr 15 , 2024 Seeking Participants with Multiple Sclerosis for Clinical Trials FREXALT CLINICAL TRIAL The FREXALT Trial The Frexalt trial designed for men and women between the ages of 18 and 55 , diagnosed with Relapsing Multiple Sclerosis ( RMS ) . The investigational medication will be given every four weeks intravenously ( IV ) . This trial is seeking 1400 participants . FREVIVA CLINICAL TRIAL The FREVIVA Trial The Freviva trial designed for men and women between the ages of 18 and 60 , diagnosed with Secondary Progressive Multiple Sclerosis ( SPMS ) . The investigational medication will be given every four weeks intravenously ( IV ) . This trial is seeking 865 participants . Consultants in Neurology CLINICAL RESEARCH 1535 Lake Cook Road , Suite 601 Northbrook , IL 60062 TEL : 847-509-0270 FAX : 847-770-6227 EFC17919 ( FREXALT ) EFC17504 ( FREVIVA ) Poster V1.0 22 March 2024